- Dr Reddy's to acquire select businesses of Wockhardt for Rs1.850 cr 13 February 2020
- Wockhardt revamps quality control team on FDA demand 20 March 2015
- Wockhardt Q2 net plunges 97% on US export ban 04 November 2014
- Wockhardt Q3 net down 29% at Rs304 crore 10 February 2014
- Wockhardt's Swiss arm to list on Berne exchange today; shares spurt 19 December 2013
- Wockhardt faces fresh strictures from UK drug regulator 23 October 2013
- Wockhardt recalls 5 drugs in UK after regulatory strictures 19 October 2013
- Wockhardt gets another slap from UK drug regulator 14 October 2013
- Wockhardt gets another blast from US drug regulator FDA 28 September 2013
- British drug regulator recalls 16 Wockhardt drugs 11 July 2013
- Wockhardt to launch generic hypertension drug in US 21 August 2012
- Cough up dues or face liquidation, HC tells Wockhardt 08 September 2011
- HC stays winding-up plea against Wockhardt 23 March 2011
- HC nod for winding up Wockhardt; company to appeal 12 March 2011
- Wockhardt launches prostate drug Flomax in the US 28 April 2010
- Bombay HC rejects plea to block Wockhardt deal with Abbott 18 January 2010
- Wockhardt gets US FDA approval for Alzheimer's drug Memantine 06 January 2010
- Fortis completes deal to pocket 10 Wockhardt hospitals 19 December 2009
- Wockhardt settles with lender DBS Bank out of court 30 November 2009
- Wockhardt reports Rs54 crore Q3 net loss 31 October 2009
- Wockhardt receives US FDA approval for prostrate drug 29 September 2009
- Wockhardt is top Indian pharma patentee; bags government award 24 September 2009
- Fortis acquires 10 Wockhardt hospitals for Rs909 crore 24 August 2009
- Wockhardt settles patent row with Orion Corporation 29 April 2009
- Wockhardt reports Rs139 crore net loss in Q4'08 25 April 2009
- Wockhardt to launch ulcer drug Ranitidine in the US 26 February 2009
- Wockhardt gets US FDA approval for paediatrics drug 04 December 2008
- Wockhardt gets USFDA approval for insomnia drug sale 14 November 2008
- Wockhardt gets US FDA nod to market Ceftazidime injections 16 October 2008
- Lintas Bangalore bags Wockhardt account 13 October 2008
- Wockhardt to demerge R&D business 18 January 2008
- Wockhardt gets US FDA nod to enter the $2.6 billion Norvasc market 17 September 2007
- The bigger picture 04 April 2007
- What the benefactors say 04 April 2007
- Wockhardt, Dr Reddy's launch generic Ondansetron in the US 27 December 2006
- FDA orders withdrawal of Wockhardt's insulin brand 'Wosulin' 25 November 2006
- Wockhardt to develop SEZ near Aurangabad for its global biopharma hub 18 September 2006
- Wockhardt's Cefotaxime injection receives US FDA approval 31 August 2006
- Wockhardt UK expanding Byetta manufacturing capacity 16 June 2006
- US FDA approves Wockhardt's Waluj plant 11 May 2006
- Wockhardt receives US FDA approval for Ranitidine OTC version 27 February 2006
- Wockhardt acquires German firm Esparma 07 May 2004
- Wockhardt buys CP Pharma 10 July 2003
- Wockhardt in talks with Watson 24 December 2001
- Pharma companies in talks with MIDC 13 December 2001
- Leading firms, Specialty Ranbaxy tie up 01 December 2001
- Wockhardt files investigational application 15 November 2001
- Drug prices revised, Wockhardt to gain 13 August 1999
- Wockhardt preparing for competition 27 April 1999
- Wockhardt to separate non-pharma business 23 April 1999
- Wockhardt sets Rs 70-crore target for nutrition business 22 April 1999
- The story so far 01 January 1900
- What Wockhardt did 01 January 1900
